HHS canceling ventilator contracts, says stockpile is full
WASHINGTON—The Trump administration is canceling some of its remaining orders for ventilators, after rushing to sign nearly $3 billion in emergency contracts as the COVID-19 pandemic surged in the spring.
The Department of Health and Human Services issued a statement Tuesday affirming that the national stockpile has now reached its maximum capacity for the life- saving breathing machines, with nearly 120,000 available for deployment to state and local health officials if needed. Though the orders were billed as a cost-saving measure, Democrats said the cancellations show the White House vastly overspent in its quest to fulfill President Donald Trump's pledge to make the United States the “King of Ventilators.”
“By terminating the remainder of deliveries from these contracts, HHS is balancing federal stock pile requirements with commercial market demand for ventilators,” said Carol Danko, an agency spokesperson. “As a result, HHS is saving the U.S.
taxpayer millions of dollars by halting delivery of additional ventilators that are no longer required.”
The agency didn't have an estimate for how much taxpayers would save by canceling the contracts because the terms and potential penalties f or the early terminations were still being negotiated with the companies involved.
H HS confirmed it was terminating contracts with ventilator manufacturers Hamilton Medical and Vyaire Medical, which will result in the reduction of 38,000 ventilators that had been scheduled for delivery to the National Strategic Stockpile by the end of 2020.
An agency spokesperson declined to comment on the status of its largest ventilator contract, a massive $647 million deal with Philips that is now the subject of an internal HHS investigation and legal review.
But Steve Klink, a spokesman for Philips at the company's headquarters in Amsterdam, confirmed that its contract had also been canceled and that it will not deliver the remaining 30,700 ventilators on its order to the U.S. stockpile.
K link said HHS had not yet given the company any “formal reason” for the cancellation.
“Unlike typically in the private sector, the U.S. government does not need any reason to terminate an agreement,” Klink said. “We can confidently say that we have delivered on our commitments. While we are disappointed in light of our massive efforts, we will work with HHS to effectuate the partial termination of this contract.”
The Philips contract has been under scrutiny because the company had signed a 2019 agreement to deliver 10,000 basic emergency ventilators to the national stockpile by 2022 at a cost of about $3,280 each. But once the COVID pandemic hit, the company inked a new deal with the Trump administration to provide 43,000 of its more complicated and expensive hospital- grade models at an average cost of about $15,000 each.